• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KCTD7 基因中的一个新的致病性变异导致神经元蜡样脂褐质沉积症(CLN14):病例报告及文献复习。

A novel pathogenic variant in the KCTD7 gene in a patient with neuronal ceroid lipofuscinosis (CLN14): a case report and review of the literature.

机构信息

Faculty of Medicine, Islamic University of Gaza, P.O. Box 108, Gaza, State of Palestine.

出版信息

BMC Neurol. 2024 Sep 30;24(1):367. doi: 10.1186/s12883-024-03868-w.

DOI:10.1186/s12883-024-03868-w
PMID:39350080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441090/
Abstract

BACKGROUND

Neuronal ceroid lipofuscinosis (NCL) is a heterogeneous group of 13 rare, progressive neurodegenerative diseases of the brain and retina. CLN14 is a very rare subtype of NCL caused by pathogenic variants in the KCTD7 gene. Only four cases of this subtype have been reported in the literature.

CASE PRESENTATION

A nine-month-old, previously healthy male who was firstborn to first-cousin parents presented with progressive psychomotor regression, dysmorphic facial features, myoclonus, and vision loss. Neurological examination showed generalized hypotonia and brisk reflexes. He continued to deteriorate until age 18 months, when he developed his first generalized tonic-clonic seizure. An ophthalmological examination showed a hypopigmented fundus and slight temporal disc pallor. Brain MRI showed mild generalized brain atrophy and white matter disease. EEG revealed a severely abnormal trace marked by generalized, high amplitude, sharply contoured, polymorphic delta slowing intermixed with theta slowing and some alpha activity, with disorganized and scattered spikes and sharp waves. The patient continued to have uncontrolled seizures and further psychomotor regression until he died of status epilepticus and pneumonia at the age of 44 months. WES identified a novel homozygous variant c.413T > C, p.(Leu138Pro) in the KCTD7 gene, causing an amino acid transition from leucine to proline at position 138. Both parents were carriers of the same variant.

CONCLUSIONS

We present the fifth known case of CLN14 in the literature and report the clinical course and a novel underlying likely causative variant in the KCTD7 gene. The improving accessibility and affordability of genetic testing will likely uncover more NCL cases and further expand the disease's genotypic and phenotypic spectrum.

摘要

背景

神经元蜡样脂褐质沉积症(NCL)是一组 13 种罕见的、进行性的脑和视网膜神经退行性疾病。CLN14 是由 KCTD7 基因突变引起的非常罕见的 NCL 亚型。该亚型在文献中仅报道过四例。

病例介绍

一名 9 月龄、此前健康的男婴,为表亲所生的第一胎,出现进行性精神运动倒退、畸形面容、肌阵挛和视力丧失。神经系统检查显示全身腱反射活跃。他持续恶化,直到 18 月龄时出现首次全面性强直阵挛发作。眼科检查显示眼底色素减退和轻微的视盘苍白。脑 MRI 显示轻度弥漫性脑萎缩和白质病变。EEG 显示严重异常的轨迹,表现为广泛性、高振幅、尖锐轮廓的多形性 δ 减速,伴有 θ 减速和一些 α 活动,伴有杂乱和分散的棘波和尖波。患儿持续出现无法控制的癫痫发作和进一步的精神运动倒退,最终因癫痫持续状态和肺炎于 44 月龄死亡。WES 鉴定出 KCTD7 基因中一个新的纯合变异 c.413T > C,p.(Leu138Pro),导致第 138 位的亮氨酸突变为脯氨酸。父母均为该变异的携带者。

结论

我们报告了文献中第五例已知的 CLN14 病例,并报道了临床病程和 KCTD7 基因中一个新的潜在致病变异。遗传检测的可及性和可负担性的提高可能会发现更多的 NCL 病例,并进一步扩大该疾病的基因型和表型谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fa/11441090/291627bc4b06/12883_2024_3868_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fa/11441090/291627bc4b06/12883_2024_3868_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fa/11441090/291627bc4b06/12883_2024_3868_Fig1_HTML.jpg

相似文献

1
A novel pathogenic variant in the KCTD7 gene in a patient with neuronal ceroid lipofuscinosis (CLN14): a case report and review of the literature.KCTD7 基因中的一个新的致病性变异导致神经元蜡样脂褐质沉积症(CLN14):病例报告及文献复习。
BMC Neurol. 2024 Sep 30;24(1):367. doi: 10.1186/s12883-024-03868-w.
2
Megalencephalic Leukoencephalopathy with Subcortical Cysts伴有皮质下囊肿的巨脑性白质脑病
3
Idiopathic (Genetic) Generalized Epilepsy特发性(遗传性)全身性癫痫
4
Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease.神经元蜡样脂褐质沉积症表型多样性的遗传原因及高分辨率成像作为视网膜疾病的标志物
Ophthalmol Sci. 2024 May 29;4(6):100560. doi: 10.1016/j.xops.2024.100560. eCollection 2024 Nov-Dec.
5
-Related Disorders-相关疾病
6
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
7
[Clinical phenotypic and genetic analysis of three children with Paroxysmal kinesigenic dyskinesia and Self-limited familial infantile epilepsy caused by PRRT2 gene mutation].[PRRT2基因突变所致3例阵发性运动诱发性运动障碍合并自限性家族性婴儿癫痫患儿的临床表型及遗传学分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025 Mar 10;42(3):292-299. doi: 10.3760/cma.j.cn511374-20240919-00498.
8
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2015 Aug 14(8):CD001911. doi: 10.1002/14651858.CD001911.pub2.
9
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.拉莫三嗪与卡马西平单药治疗癫痫的疗效比较:个体参与者数据回顾
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD001031. doi: 10.1002/14651858.CD001031.pub4.
10
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.

本文引用的文献

1
KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature.KCTD7 相关性进行性肌阵挛癫痫:42 例报告及文献复习。
Epilepsia. 2024 Mar;65(3):709-724. doi: 10.1111/epi.17880. Epub 2024 Jan 17.
2
Kctd7 deficiency induces myoclonic seizures associated with Purkinje cell death and microvascular defects.Kctd7 缺乏诱导肌阵挛发作,伴浦肯野细胞死亡和微血管缺陷。
Dis Model Mech. 2022 Sep 1;15(9). doi: 10.1242/dmm.049642. Epub 2022 Sep 13.
3
KCTD7 mutations impair the trafficking of lysosomal enzymes through CLN5 accumulation to cause neuronal ceroid lipofuscinoses.
KCTD7 突变通过 CLN5 积累损害溶酶体酶的运输,从而导致神经元蜡样脂褐质沉积症。
Sci Adv. 2022 Aug 5;8(31):eabm5578. doi: 10.1126/sciadv.abm5578. Epub 2022 Aug 3.
4
Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.神经元蜡样脂褐质沉积症的遗传基础、临床特征和诊断方法的最新研究进展。
Int J Mol Sci. 2022 May 20;23(10):5729. doi: 10.3390/ijms23105729.
5
Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.神经元蜡样脂褐质沉积症:临床问题的多方面探讨,综述
Front Neurol. 2022 Mar 11;13:811686. doi: 10.3389/fneur.2022.811686. eCollection 2022.
6
The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses.神经元蜡样脂褐质沉积症表型异质性的遗传基础
Front Neurol. 2021 Oct 18;12:754045. doi: 10.3389/fneur.2021.754045. eCollection 2021.
7
Neuronal Ceroid Lipofuscinoses in Children.儿童神经元蜡样脂褐质沉积症
Ann Indian Acad Neurol. 2021 Mar-Apr;24(2):192-197. doi: 10.4103/aian.AIAN_61_20. Epub 2021 Apr 28.
8
Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.神经元蜡样脂褐质沉积症的治疗进展
Expert Opin Orphan Drugs. 2019;7(11):473-500. doi: 10.1080/21678707.2019.1684258. Epub 2019 Nov 27.
9
Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers.俄罗斯人群中的神经元蜡样脂褐质沉积症:两种新的突变和杂合子携带者的流行率。
Mol Genet Genomic Med. 2020 Jul;8(7):e1228. doi: 10.1002/mgg3.1228. Epub 2020 May 15.
10
Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2.Cerliponase Alfa 综述:用于晚发性婴儿神经元蜡样脂褐质沉积症 2 型的重组人酶替代治疗。
J Child Neurol. 2020 Apr;35(5):348-353. doi: 10.1177/0883073819895694. Epub 2019 Dec 29.